AT365193B - Verfahren zur herstellung von neuen beta-lactam- -verbindungen - Google Patents

Verfahren zur herstellung von neuen beta-lactam- -verbindungen

Info

Publication number
AT365193B
AT365193B AT0510878A AT510878A AT365193B AT 365193 B AT365193 B AT 365193B AT 0510878 A AT0510878 A AT 0510878A AT 510878 A AT510878 A AT 510878A AT 365193 B AT365193 B AT 365193B
Authority
AT
Austria
Prior art keywords
producing new
lactam compounds
beta lactam
new beta
compounds
Prior art date
Application number
AT0510878A
Other languages
German (de)
English (en)
Other versions
ATA510878A (de
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ATA510878A publication Critical patent/ATA510878A/de
Application granted granted Critical
Publication of AT365193B publication Critical patent/AT365193B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT0510878A 1977-07-16 1978-07-14 Verfahren zur herstellung von neuen beta-lactam- -verbindungen AT365193B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772732283 DE2732283A1 (de) 1977-07-16 1977-07-16 Beta-lactam-verbindungen

Publications (2)

Publication Number Publication Date
ATA510878A ATA510878A (de) 1981-05-15
AT365193B true AT365193B (de) 1981-12-28

Family

ID=6014140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0510878A AT365193B (de) 1977-07-16 1978-07-14 Verfahren zur herstellung von neuen beta-lactam- -verbindungen

Country Status (11)

Country Link
US (2) US4215118A (es)
EP (1) EP0000392B1 (es)
JP (1) JPS5439091A (es)
AT (1) AT365193B (es)
AU (1) AU525027B2 (es)
CA (1) CA1122593A (es)
DE (2) DE2732283A1 (es)
DK (1) DK318278A (es)
ES (1) ES471770A1 (es)
IL (1) IL55130A (es)
IT (1) IT1097816B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA813610B (en) * 1980-06-06 1982-06-30 Beecham Group Plc Penicillin derivatives,processes for their preparation and compositions containing them
NZ197416A (en) * 1980-06-26 1983-11-18 Beecham Group Ltd Penicillin derivatives and pharmaceutical compositions
US4436904A (en) * 1981-02-14 1984-03-13 Kanto Ishi Pharmaceutical Co., Ltd. Cephalosporins
EP0066406A1 (en) * 1981-05-28 1982-12-08 Beecham Group Plc Beta-lactam antibiotics
DE3215085A1 (de) * 1982-04-22 1983-10-27 Bayer Ag, 5090 Leverkusen Ss-lactam-antibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3431273A1 (de) * 1984-08-25 1986-03-06 Bayer Ag, 5090 Leverkusen Kristallines natriumsalz der d-6-((alpha)-(2-oxo-3-furfuryl-iden-amino-imidazolidin-1-yl)-carbonylamino)-thienyl-2-acetamido)-penicillansaeure, verfahren zur herstellung und seine verwendung in arzneimitteln
GB8519264D0 (en) * 1985-07-31 1985-09-04 Baldwin J E Chemical compounds
GB8713061D0 (en) * 1987-06-04 1987-07-08 Beecham Group Plc Compounds
AU782938B2 (en) * 2001-08-28 2005-09-08 Boss Rubber Technologies Pty Ltd Resilient product

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687949A (en) * 1969-01-21 1972-08-29 Bristol Myers Co Synthetic cephalosporins
US3959258A (en) * 1970-05-25 1976-05-25 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US4086340A (en) * 1974-02-18 1978-04-25 Bayer Aktiengesellschaft Cephalosporins and their production
US4087424A (en) * 1974-05-09 1978-05-02 Toyama Chemical Co., Ltd. Novel penicillins and cephalosporins and process for producing the same
GB1486349A (en) * 1974-11-28 1977-09-21 Bayer Ag Beta-lactam antibiotics process for their preparation and their use as medicaments
JPS5852996B2 (ja) * 1975-03-25 1983-11-26 バイエル・アクチエンゲゼルシヤフト β−ラクタム及び抗バクテリア剤
DE2633317A1 (de) * 1976-07-23 1978-01-26 Bayer Ag Beta-lactamantibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
CA1122593A (en) 1982-04-27
IT7825714A0 (it) 1978-07-14
EP0000392A2 (de) 1979-01-24
US4338434A (en) 1982-07-06
DE2732283A1 (de) 1979-01-25
IL55130A (en) 1982-01-31
EP0000392A3 (en) 1979-08-22
ATA510878A (de) 1981-05-15
ES471770A1 (es) 1979-02-01
DE2861766D1 (en) 1982-06-09
AU525027B2 (en) 1982-10-14
IL55130A0 (en) 1978-09-29
DK318278A (da) 1979-01-17
EP0000392B1 (de) 1982-04-28
AU3801878A (en) 1980-01-17
IT1097816B (it) 1985-08-31
JPS5439091A (en) 1979-03-24
US4215118A (en) 1980-07-29

Similar Documents

Publication Publication Date Title
AT367425B (de) Verfahren zur herstellung von neuen cephemderivaten
AT372093B (de) Verfahren zur herstellung von neuen corticoid-17- alkylcarbonaten
AT362065B (de) Verfahren zur herstellung von neuen pleuromutilinglycosidderivaten
LU79212A1 (de) Verfahren zur herstellung von neuen 4-acylamino-phenylaethanolaminen
AT363182B (de) Verfahren zur herstellung von neuen cephemderivaten
AT367409B (de) Verfahren zur herstellung von neuen nsubstituierten epsilon-caprolactamverbindungen
AT371455B (de) Verfahren zur herstellung von neuen prostanderivaten
AT368753B (de) Verfahren zur herstellung von neuen azacycloalkanen
AT361455B (de) Verfahren zur herstellung von neuen substituierten 3-phenyl-cycloalkan- oder - -cycloalken-1-olen
AT368137B (de) Verfahren zur herstellung von neuen 4-amino-5alkylthiopyrimidinen
AT366368B (de) Verfahren zur herstellung von neuen chinolylguanidinen
AT357673B (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
AT365193B (de) Verfahren zur herstellung von neuen beta-lactam- -verbindungen
AT361622B (de) Verfahren zur herstellung von neuen anthra- cyclinglycosid-anitbiotika
AT365591B (de) Verfahren zur herstellung von neuen indolderivaten
AT357677B (de) Verfahren zur herstellung von neuen azacyclyl- -verbindungen
AT372690B (de) Verfahren zur herstellung von neuen polyhydantoinen
ATA788777A (de) Verfahren zur herstellung von neuen lactamen
AT360676B (de) Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen
AT368159B (de) Verfahren zur herstellung von neuen beta-lactam -verbindungen
ATA750578A (de) Verfahren zur herstellung von neuen pyridothiazo- linen
AT365203B (de) Verfahren zur herstellung von neuen 9-fluorprednisolon-derivaten
AT372954B (de) Verfahren zur herstellung von neuen spirobenzofuranonverbindungen
AT359517B (de) Verfahren zur herstellung von neuen alfa- -halogenaethylcarbamidsaeurehalogeniden
AT365610B (de) Verfahren zur herstellung von neuen 19-nor-10cyano-peruvosid-derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee